Cargando…
Long‐term survival of nonlocalized epithelial ovarian cancer among women using menopausal hormone therapy prior to diagnosis: The extreme study
Prediagnostic use of menopausal hormone therapy (MHT) has been suggested to be associated with improved survival of epithelial ovarian cancer (EOC). We investigated the potential long‐term survival benefit of prediagnostic MHT use in women ≥50 years with nonlocalized EOC using the Extreme study incl...
Autores principales: | Baandrup, Louise, Galanakis, Michael, Hannibal, Charlotte G., Dehlendorff, Christian, Hertzum‐Larsen, Rasmus, Mørch, Lina S., Kjaer, Susanne K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541581/ https://www.ncbi.nlm.nih.gov/pubmed/35716136 http://dx.doi.org/10.1002/ijc.34171 |
Ejemplares similares
-
Risk of nonovarian cancer in a nationwide‐based study of nearly 5000 women with borderline ovarian tumors in Denmark
por: Hannibal, Charlotte G., et al.
Publicado: (2022) -
Incidence of cervical precancerous lesions and cervical cancer in Denmark from 2000 to 2019: Population impact of multi‐cohort vaccination against human papillomavirus infection
por: Ring, Linea Landgrebe, et al.
Publicado: (2022) -
Aspirin use and ovarian cancer mortality in a Danish nationwide cohort study
por: Verdoodt, Freija, et al.
Publicado: (2018) -
A nationwide longitudinal study on risk factors for progression of anal intraepithelial neoplasia grade 3 to anal cancer
por: Faber, Mette T., et al.
Publicado: (2022) -
An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk
por: Lee, S A, et al.
Publicado: (2005)